ClinicalTrials.gg
CompletedNCT05704322Updated Dec 18, 2024

The Effectiveness of the Wim Hof Method in People with Spinal Cord Injury

An interventional study of Wim Hof Methode in Spinal Cord Injuries, sponsored by Stichting Reade. Completed at 1 site in Netherlands. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-18.

Sponsored by Stichting Reade · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 22 studies in Spinal Cord Injuries with a site in Netherlands — 5 open to participants now, 6 under way, none of them phase 3. Spinal Cord Injuries · Netherlands.

Enrollment
2nd of 18
60 · median 18
Started
2023
with 4 others
No phase
17 of 22
5 open now
Registered
9th of 22
by date
Lead sponsor
3 of 22
Stichting Reade

Among the 22 studies in Spinal Cord Injuries with a site in Netherlands, this one is the 2nd largest by enrollment of the 18 interventional ones that give a count, is one of 5 that started in 2023, is one of 17 with no phase, and was the 9th registered.

Spinal Cord Injuries

2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.

Browse Spinal Cord Injuries studies →

Open to participants now

5 of the 22 studies in Spinal Cord Injuries with a site in Netherlands are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in Netherlands have not opened yet or have stopped. Only those recruiting at a site in Netherlands →

Who these studies take

Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.

This study: 18 Years to 75 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 22 studies in Spinal Cord Injuries with a site in Netherlands, or all of them as a file.
02

Study summary

People with a spinal cord injury (SCI) often experience secondary medical complications. One of the methods that may help to prevent or deal with secondary complications in people with SCI is the Wim Hof Method (WHM). The WHM is based on three elements: 1) breathing exercises, 2) gradual cold exposure (cold showers, or cold water immersion), and 3) mindset. The primary objective of this randomized controlled trial is to assess the effects of WHM, involving breathing exercises, mindset (and cold exposure), on health-related quality of life in people with SCI. The secondary objectives are to assess the effects of WHM, involving breathing exercises, mindset (and cold exposure) in people with SCI on: inflammation markers, metabolic health, pulmonary function, body composition, sleep quality, spasticity, stress, and on chronic pain.

Read the detailed description

A spinal cord injury (SCI) is a serious medical condition that causes functional, psychological and socioeconomic disorder. Long-term, secondary medical complications are common and play an important role in the continuum of care for people with SCI. Complications are a frequent cause of morbidity and mortality and lead to increased rates of rehospitalisation, loss of employability and decreased quality of life. During multidisciplinary SCI rehabilitation, the treatment is focussed on working with the patient physically and psychologically to maximize their neurological recovery and general health but also to prevent or deal with the secondary complications. One of the methods that may help to prevent or deal with secondary complications in people with SCI is the Wim Hof Method (WHM). The WHM is based on three elements: 1) breathing exercises, 2) gradual cold exposure (cold showers, or cold water immersion), and 3) mindset. Previous studies showed a positive effect of the WHM on health-related quality of life and the inflammatory profile of healthy individuals as well as patients with active axial spondyloarthritis. Furthermore, a pilot study in people with SCI showed that the WHM (only breathing exercises and mindset) led to positive changes in respiratory function, mental health index, hyperventilation and a trend was visible regarding the hindrance due to spasticity. Some of the participants mentioned that they experienced positive effects on coughing, energy level, mood or used less spasticity medication after the WHM intervention. These positive findings in the pilot study warrant a full-scale randomised-controlled trial (RCT) of this novel therapeutic approach in people with SCI.

The primary objective of this randomized controlled trial is to assess the effects of WHM, involving breathing exercises, mindset (and cold exposure), on health-related quality of life in people with SCI. The secondary objectives are to assess the effects of WHM, involving breathing exercises, mindset (and cold exposure) in people with SCI on: inflammation markers, metabolic health, pulmonary function, body composition, sleep quality, spasticity, stress, and on chronic pain.

03

Conditions studied

  • Spinal Cord Injuries
04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Individuals (Male/Female) with either a complete or incomplete chronic SCI. In this study, a chronic SCI is defined as a time since injury ≥ 1 year.
  • Participants have to be between 18 and 75 years old.

Exclusion criteria

Exclusion Criteria:

  • Cardiac arrhythmias or cardiac disease;
  • A history of severe autonomic dysreflexia assessed with the 'Autonomic standards assessment';
  • Severe pulmonary disease (such as ) based on a pulmonary history;
  • Insufficient mastery of the Dutch language (speaking and reading);
  • Severe cognitive or communicative disorders;
  • Progressive disease;
  • Being or becoming pregnant during the study period;
  • Severe psychiatric illness or disorders (at the discretion of the treating rehabilitation physician);
  • Involved in another intervention study which may have an effect on the outcome measures of the present study;
  • Experience with (parts of) the Wim Hof Method.
  • Negative advice from physician to participate in the Wim Hof Method intervention based on the medical screening.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • No intervention
    Usual care group

    The control group will not receive any intervention, they will receive usual care and only participate in the pre and post tests.

  • Experimental
    Wim Hof Method - breathing and mindset exercise

    The first intervention group will practice the breathing and mindset exercise.

    Other: Wim Hof Methode

  • Experimental
    Wim Hof Method - breathing and mindset exercise and cold exposure

    The second intervention group will also practice the cold exposure (i.e, breathing, mindset and cold exposure)

    Other: Wim Hof Methode

Interventions

  • OtherWim Hof Methode

    The intervention groups will follow a 7-weeks intervention, with one practice session per week at the rehabilitation center led by Wim Hof or one of his instructors. Besides these joint weekly sessions, the intervention groups have to practice daily at home with the Wim Hof Method app.

06

What researchers measure

Primary outcomes

  1. Change in mental health

    Mental Health Index - 5 (MHI-5), a subscale of the SF-36. The MHI-5 has a score of 0 to 100, where a score of 100 represents optimal mental health.

    Time frame: Assessed before and after the 7-weeks WHM intervention

Secondary outcomes

  1. Change in health-related quality of life

    The SF-36 measures measures eight health concepts: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions. Each scale is scored on a 0 to 100 range, a higher score defines a more favorable health state.

    Time frame: Assessed before and after the 7-weeks WHM intervention

  2. Change in mindful attention awareness

    The Mindful Attention Awareness Scale is a 15-item scale designed to assess a core characteristic of mindfulness. Each item can be scored from 1 (almost always) to 6 (almost never). The overall outcome is the average of the 15 items, with a higher score indicating being more mindful.

    Time frame: Assessed before and after the 7-weeks WHM intervention

  3. Change in hyperventilation

    The Nijmegen Hyperventilation Syndrome Questionnaire has 16 items (related to symptoms of hyperventilation syndrome) to be answered on a 5-point scale ranging from 'never' (0) to 'very often' (4). A total score of more than 23 out of 64 points suggests significant hyperventilation.

    Time frame: Assessed before and after the 7-weeks WHM intervention

  4. Change in pain and pain interference

    Four questions of the International Spinal Cord Injury Pain basic data set will be used to assess (the interference of) pain on a 0 (no pain or no interference) to 10 (extreme pain or extreme interference) range.

    Time frame: Assessed before and after the 7-weeks WHM intervention

  5. Change in sleep quality

    Pittsburgh Sleep Quality Index (PSQI) is a self-rating questionnaire resulting in a global score between 0 and 21, which consists of seven subscores. Higher scores indicate worse sleep quality.

    Time frame: Assessed before and after the 7-weeks WHM intervention

  6. Change in hindrance due to spasticity

    Hindrance due to spasticity will be assessed with a subjective rating scale for each of the following activities: (1) sleeping; (2) making transfers; (3) washing and clothing; (4) wheelchair driving; (5) 'others'. The scale ranges from 0 to 2 (0: no hindrance due to spasticity; 1: little hindrance due to spasticity; 2: a lot of hindrance due to spasticity). A sum score for hindrance during all activities will be calculated. It ranges from 0 (no hindrance) to 10 (a lot of hindrance during all activities).

    Time frame: Assessed before and after the 7-weeks WHM intervention

  7. Change in CRP

    Concentration CRP (mg/L) in blood

    Time frame: Assessed before and after the 7-weeks WHM intervention

  8. Change in IL-6

    Concentration IL-6 (pg/ml) in blood

    Time frame: Assessed before and after the 7-weeks WHM intervention

  9. Change in fasted glucose

    Concentration of fasted glucose (mmol/l) in blood

    Time frame: Assessed before and after the 7-weeks WHM intervention

  10. Change in triglycerides

    Concentration of triglycerides (mmol/l) in blood

    Time frame: Assessed before and after the 7-weeks WHM intervention

  11. Change in high-density lipoprotein

    Concentration of high-density lipoprotein (mmol/l) in blood

    Time frame: Assessed before and after the 7-weeks WHM intervention

  12. Change in low-density lipoprotein

    Concentration of low-density lipoprotein (mmol/l) in blood

    Time frame: Assessed before and after the 7-weeks WHM intervention

  13. Change in total cholesterol

    Concentration of total cholesterol (mmol/l) in blood

    Time frame: Assessed before and after the 7-weeks WHM intervention

  14. Change in blood pressure

    Systolic and diastolic blood pressure (mm Hg)

    Time frame: Assessed before and after the 7-weeks WHM intervention

  15. Change in forced vital capacity

    Forced vital capacity (FVC, liter) measured by spirometry

    Time frame: Assessed before and after the 7-weeks WHM intervention

  16. Change in forced expiratory volume

    Forced expiratory volume in 1 sec (FEV1, liter) measured by spirometry

    Time frame: Assessed before and after the 7-weeks WHM intervention

  17. Change in forced inspiratory volume

    Forced inspiratory volume in 1 sec (FIV1, liter) measured by spirometry

    Time frame: Assessed before and after the 7-weeks WHM intervention

  18. Change in peak expiratory flow

    Peak expiratory flow (PEF, liter/s) measured by spirometry

    Time frame: Assessed before and after the 7-weeks WHM intervention

  19. Change in peak inspiratory flow

    Peak inspiratory flow (PIF, liter/s) measured by spirometry

    Time frame: Assessed before and after the 7-weeks WHM intervention

  20. Change in body mass

    Body mass (kg) measured on a (wheelchair) weighing scale

    Time frame: Assessed before and after the 7-weeks WHM intervention

  21. Change in fat and fat free mass

    Fat mass and fat free mass (both in kg) measured by bio-impedance analysis:

    Time frame: Assessed before and after the 7-weeks WHM intervention

  22. Participant compliance and experiences

    Diary and exit interview

    Time frame: Assessed before and after the 7-weeks WHM intervention

07

Study locations

1 site
  • Stichting Reade
    Amsterdam, 1054HW, Netherlands
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2023 to primary completion in Dec 2024, 20 months.

Of 791 non-industry interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 65. This study's 20 months is below that.

Counting every sponsor, half of 840 studies reached it within 36 months; a quarter within 17 and three quarters within 64.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 29, 2022
First posted
Jan 30, 2023
StartActual
Mar 27, 2023
Primary completionActual
Dec 1, 2024
CompletionActual
Dec 1, 2024
Last update
Dec 18, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 18, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05704322
Lead sponsor
Stichting Reade
Collaborators
Dr. C.J. Vaillant Fonds, W.M. de Hoop Stichting, Ars Donandi / Yske Walther fonds, Reade foundation
Responsible party
Sponsor
First posted
Jan 30, 2023
Start date
Mar 27, 2023
Primary completion
Dec 1, 2024
Completion
Dec 1, 2024
Last update
Dec 18, 2024

Study contacts

Sonja de Groot, PhD
principal investigator · Stichting Reade

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion